Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Allakos
Biotech
Concentra scoops up near-defunct Allakos
Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement after being denied by Pliant Therapeutics and Acelyrin.
Zoey Becker
Apr 2, 2025 5:05pm
Allakos axes program, lays off 75% of staff after phase 1 flop
Jan 27, 2025 8:46am
Allakos drops lead asset after midphase flops, halves headcount
Jan 16, 2024 9:26am
Allakos' failed phase 3 EoDyssey sinks gastrointestinal program
Sep 9, 2022 9:32am
Alta raises $130M for its new biotech VC fund, missing its goal
Jun 13, 2018 2:32pm
Allergy, inflammation player Allakos reels in $100M series B
Dec 13, 2017 5:09pm
